These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22800197)

  • 1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.
    Herraez E; Gonzalez-Sanchez E; Vaquero J; Romero MR; Serrano MA; Marin JJ; Briz O
    Mol Pharm; 2012 Sep; 9(9):2565-76. PubMed ID: 22800197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1.
    Herraez E; Sanchez-Vicente L; Macias RIR; Briz O; Marin JJG
    Oncotarget; 2017 May; 8(21):34617-34629. PubMed ID: 28423714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.
    Martinez-Becerra P; Monte I; Romero MR; Serrano MA; Vaquero J; Macias RI; Del Rio A; Grañé-Boladeras N; Jimenez F; San-Martin FG; Pastor-Anglada M; Marin JJ
    Pharmacol Res; 2012 Nov; 66(5):419-27. PubMed ID: 22898327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.
    Vaquero J; Briz O; Herraez E; Muntané J; Marin JJ
    Biochim Biophys Acta; 2013 Oct; 1833(10):2212-9. PubMed ID: 23680185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
    Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
    Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
    Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer.
    De Gottardi A; Touri F; Maurer CA; Perez A; Maurhofer O; Ventre G; Bentzen CL; Niesor EJ; Dufour JF
    Dig Dis Sci; 2004 Jun; 49(6):982-9. PubMed ID: 15309887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation.
    Sun AQ; Luo Y; Backos DS; Xu S; Balasubramaniyan N; Reigan P; Suchy FJ
    Mol Pharmacol; 2013 May; 83(5):1078-86. PubMed ID: 23462506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.
    Frankenberg T; Rao A; Chen F; Haywood J; Shneider BL; Dawson PA
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G912-22. PubMed ID: 16357058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
    Komatani H; Kotani H; Hara Y; Nakagawa R; Matsumoto M; Arakawa H; Nishimura S
    Cancer Res; 2001 Apr; 61(7):2827-32. PubMed ID: 11306452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
    Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
    Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
    Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
    J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
    Kowalski P; Surowiak P; Lage H
    Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver.
    Rosales R; Romero MR; Vaquero J; Monte MJ; Requena P; Martinez-Augustin O; Sanchez de Medina F; Marin JJ
    Biochem Pharmacol; 2013 Mar; 85(6):829-38. PubMed ID: 23313557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
    Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
    Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.